Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.

Sheba Study Indicates: Pfizer-BioNTech COVID-19 Vaccine Effective Against Omicron Variant

COVID-19 Vaccine Protects Against Severe Illness
According to a study conducted by Sheba Medical Center and the Israeli Ministry of Health, three doses of the Pfizer-BioNTech COVID-19 vaccine provide significant protection against the Omicron variant.

Following the emergence of the COVID-19 Omicron variant, many wondered if existing vaccines would provide adequate protection. A recent study conducted by Sheba Medical Center and the Israeli Ministry of Health attempted to address concerns.

The study evaluated the efficacy of existing COVID-19 vaccines against the Omicron variant and confirmed that receiving three doses of the Pfizer-BioNTech COVID-19 vaccine will provide significant protection against the Omicron variant, as results indicate that the vaccine prevents severe illness.

In contrast, the study found that two doses of the vaccine are not likely to be effective against the Omicron variant. Thus, an individual vaccinated only twice remains at high risk of contracting the variant and becoming seriously ill.

According to Prof. Gili Regev-Yochay, Head of the Infection Prevention and Control Unit at Sheba, who also led the study: “The findings emphasized the importance of increasing the vaccination rates as an effective and necessary measure to stop the spread of the virus.”

Sheba and Mayo Clinic merge Data-Sharing Network
News May 18.
Sheba and Mayo Clinic Partner to Transform Patient Care Through an Innovative Data-Sharing Network
Sheba Medical Center has joined the Mayo Clinic Platform Connect, a global data-sharing network that aims to revolutionize healthcare. The groundbreaking platform provides a safe,…
Read More
Sheba Medical Center is working on enhancing patient safety with AI solutions.
News May 18.
Enhancing Patient Safety and Care with AI Solutions
With improving patient care a top priority, Sheba recognized technological innovation as an essential enabler of progress and transformation, with a particular emphasis on artificial…
Read More
IBD passport for patients with ulcerative colitis.
News May 17.
Meet the IBD Passport: A New Hope for Ulcerative Colitis and Crohn’s Disease Patients 
Ulcerative colitis (UC) and Crohn’s disease, the two most common forms of inflammatory bowel disease (IBD), can cause frustrating symptoms like diarrhea, abdominal pain, bloating,…
Read More